Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AL2846 + Chemotherapy in Advanced Colorectal Cancer
NCT04337879Phase 2Unknown
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Jul 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vilzemetkib in colorectal cancer (CRC), sponsored by Chia Tai-Tianqing Pharmaceutical Group. Status: unknown.
02
Drugs
vilzemetkib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT04337879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04337879.